Amlodipine Completed Phase 4 Trials for Nonvalvular Atrial Fibrillation Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT02734355Left Atrial Mechanical Function Improvement After Atrial Fibrillation Catheter Ablation
NCT00438113Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent AF